ASTAL LABORATORIES LIMITED
ASTAL LABORATORIES LIMITED is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under BSE: 512600 (ISIN INE307N01014).
It has a market capitalisation of ₹282 crore, a last close of ₹66.82 on 2026-10-19, a one-year return of -33.6%.
Valuation: a price-to-earnings ratio of 28.99x, a price-to-book ratio of 0.86x.
Profitability: return on equity of 4.5%, return on capital employed of 6.7%, an operating margin of 8.8%.
Growth: sales growth of 257.0% a year over three years, net profit growth of 691.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.04x, promoter holding of 4.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 282 |
| Last close | ₹66.82 |
| P/E (TTM) | 28.99x |
| P/B | 0.86x |
| ROE (FY) | 4.5% |
| ROCE (FY) | 6.7% |
| Operating margin (TTM) | 8.8% |
| Sales growth, 3-year CAGR | 257.0% |
| Profit growth, 3-year CAGR | 691.0% |
| Debt / equity | 0.04x |
| Promoter holding | 4.6% |
| 1-year return | -33.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means